Risk factors for the development of reversible psychomotor dysfunction following prolonged isoflurane inhalation in the general intensive care unit

Journal of Clinical Anesthesia

Volumn 21, Issue 8, 2009, Pages 567-573

  Ariyama, Jun ^a   Hayashida, Masakazu ^a   Shibata, Keizo ^b   Sugimoto, Yuji ^b   Imanishi, Hirokazu ^a   O oi, Yoshiyuki ^c   Kitamura, Akira ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^b Intensive Care Unit   (Japan)

^c NIHON UNIVERSITY   (Japan)

Author keywords

Hallucination; Involuntary movement; Isoflurane; Mechanical ventilation; Sedation

Indexed keywords

ISOFLURANE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHOREA; CONTROLLED STUDY; FEMALE; GENERAL HOSPITAL; HALLUCINATION; HUMAN; INCIDENCE; INFANT; INHALATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RISK FACTOR; SCHOOL CHILD; SEDATION; SEX DIFFERENCE; TREMOR; WEANING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, INHALATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INTENSIVE CARE UNITS; ISOFLURANE; MALE; MIDDLE AGED; PSYCHOMOTOR DISORDERS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72149099612     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2009.01.011     Document Type: Article

References (26)

1. Ostermann M.E., Keenan S.P., Seiferling R.A., et al. Sedation in the intensive care unit. JAMA 283 (2000) 1451-1459
2. Spencer E.M., and Willatts S.M. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med 18 (1992) 415-421
3. Kong K.L., Willatts S.M., and Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ 298 (1989) 1277-1280
4. Kong K.L., Willatts S.M., Prys-Roberts C., et al. Plasma catecholamine concentration during sedation in ventilated patients requiring intensive therapy. Intensive Care Med 16 (1990) 171-174
5. Tanigami H., Yahagi N., Kumon K., et al. Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artif Organs 21 (1997) 21-23
6. Sackey P.V., Martling C.R., Granath F., et al. Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device. Crit Care Med 32 (2004) 2241-2246
7. Sackey P.V., Martling C.R., Carlswärd C., et al. Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam-a pilot study. Crit Care Med 36 (2008) 801-806
8. Shankar V., Churchwell K.B., and Deshpande J.K. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med 32 (2006) 927-933
9. Kelsall A.W., Ross-Russell R., and Herrick M.J. Reversible neurologic dysfunction following isoflurane sedation in pediatric intensive care. Crit Care Med 22 (1994) 1032-1034
10. Arnold J.H., Truog R.D., and Rice S.A. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg 76 (1993) 520-526
11. McBeth C., and Watkins T.G. Isoflurane for sedation in a case of congenital myasthenia gravis. Br J Anaesth 77 (1996) 672-674
12. Hughes J., Leach H.J., and Choonara I. Hallucinations on withdrawal of isoflurane used as sedation. Acta Paediatr 82 (1993) 885-886
13. Stevens J.J., Griffin R.M., and Stow P.J. Prolonged use of isoflurane in a patient with tetanus. Br J Anaesth 70 (1993) 107-109
14. Bergman I., Steeves M., Burckart G., and Thompson A. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr 119 (1991) 644-649
15. Dominguez K.D., Crowley M.R., Coleman D.M., et al. Withdrawal from lorazepam in critically ill children. Ann Pharmacother 40 (2006) 1035-1039
16. Katz R., Kelly H.W., and Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 22 (1994) 763-767
17. Road J., Mackie G., Jiang T.X., et al. Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiological correlates. Muscle Nerve 20 (1997) 1587-1590
18. Chu N.S. Caffeine- and aminophylline-induced seizures. Epilepsia 22 (1981) 85-94
19. Sponheim S., Skraastad O., Helseth E., et al. Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Anaesthesiol Scand 47 (2003) 932-938
20. Koerner I.P., and Brambrink A.M. Brain protection by anesthetic agents. Curr Opin Anaesthesiol 19 (2006) 481-486
21. Eger II E.I., Stevens W.C., and Cromwell T.H. The electroencephalogram in man anesthetized with forane. Anesthesiology 35 (1971) 504-508
22. Javtovic-Todorovic V., Hartman R.E., Izumi Y., et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat and persistent learning deficits. J Neurosci 23 (2003) 876-882
23. Soriano S.G., and Anand K.J. Anesthetics and brain toxicity. Curr Opin Anaesthesiol 18 (2005) 293-297
24. Mellon R.D., Simone A.F., and Rappaport B.A. Use of anesthetic agents in neonates and young children. Anesth Analg 104 (2007) 509-520
25. Pandharipand P., Cotton B.A., Shintani A., et al. Motoric subtype of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 33 (2007) 1726-1731
26. Kang T.M. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 36 (2002) 1453-1456